Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Blow-Fill-Seal Technology Market Set To Climb From $4.41 Billion In 2026 To $6.95 Billion By 2030
The market size for blow-fill-seal technology has expanded rapidly over recent years. It is anticipated to increase from $3.94 billion in 2025 to $4.41 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.8%. Historically, this expansion has been driven by factors such as the rising demand for sterile pharmaceutical packaging, the growth in injectable drug production, increased regulatory scrutiny on aseptic manufacturing, the proliferation of liquid pharmaceutical formulations, and the adoption of automated filling technologies.
The blow-fill-seal technology market is projected to experience substantial expansion over the coming years. Its valuation is forecast to reach $6.95 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.1%. This projected growth is linked to factors such as the increasing production of biologics and vaccines, heightened investments in sophisticated aseptic processing, a rising demand for convenient ready-to-use packaging, the broadening application of BFS in food and beverage packaging, and an enhanced emphasis on manufacturing efficiency and adherence to regulations. Key trends anticipated during this period encompass the greater embrace of fully automated aseptic packaging lines, an escalating need for contamination-free production environments, the expanding utilization of single-step container forming methods, the scaling up of high-speed BFS manufacturing capacities, and a sharpened focus on packaging solutions that meet regulatory standards.
Get A Free Sample Report With In-Depth Market Insights:
Blow-Fill-Seal Technology Market Growth Factors: What’s Supporting Expansion?
The expanding pharmaceutical sector is anticipated to fuel the future expansion of the blow-fill-seal technology market. This industry encompasses the exploration, creation, and manufacturing of drugs and treatments. Blow-fill-seal (BFS) technology provides product packaging solutions that safeguard items against physical harm, chemical impurities, and microbial spoilage. For example, data from November 2024, provided by the European Federation of Pharmaceutical Industries and Associations (EFPIA), a trade group based in Belgium, indicated that in 2024, North America constituted 54.8% of worldwide pharmaceutical sales, with Europe making up 22.7%. Consequently, the burgeoning pharmaceutical industry is serving as a catalyst for the blow-fill-seal technology market’s growth.
Blow-Fill-Seal Technology Market Segment Analysis And Revenue Potential
The blow-fill-seal technology market covered in this report is segmented –
1) By Product Type: Bottles, Ampoules, Vials, Prefilled Syringes And Injectables
2) By Material Type: Polyethylene (PE), Polypropylene (PP), Other Materials
3) By Specification: Small Volume, Large Volume
4) By End Use: Pharmaceuticals, Food And Beverage, Cosmetics And Personal Care, Other End Users
Subsegments:
1) By Bottles: Plastic Bottles, Glass Bottles
2) By Ampoules: Glass Ampoules, Plastic Ampoules
3) By Vials: Glass Vials, Plastic Vials
4) By Prefilled Syringes And Injectables: Glass Blow-Fill-Seal (BFS) Prefilled Syringes, Plastic Blow-Fill-Seal (BFS) Prefilled Syringes, Single-Dose Injectable Blow-Fill-Seal (BFS), Multi-Dose Injectable Blow-Fill-Seal (BFS)
Blow-Fill-Seal Technology Market Industry Trends: What’s Reshaping Demand?
Major companies in the blow-fill-seal technology market are prioritizing the creation of innovative solutions, such as closed-parison aseptic BFS platforms, to address the growing need for high-purity sterile packaging, flexible small-volume parenteral production, and contamination-free drug delivery systems for vaccines, biologics, and ophthalmic formulations. A closed-parison aseptic BFS platform is a Blow-Fill-Seal system in which the plastic parison, the molten tube forming the container, is fully encased during its formation and filling, establishing a sealed Grade A sterile environment. This process prevents external contamination, enhances sterility assurance, improves adherence to strict GMP requirements, and enables the safe processing of sensitive products like vaccines, biologics, and ophthalmic formulations. For instance, in October 2024, Brevetti Angela Srl, an Italy-based manufacturing company, launched the SYFPAC DUO BFS platform, an advanced aseptic packaging system unveiled at the 2024 CPHI Worldwide Pharma Expo in Milan. The system features an ultra-compact 6 m² footprint and a scalable output ranging from 4,000 to 40,000 units per hour, offering one of the highest productivity-to-size ratios in the market. It incorporates Closed Parison technology, enabling sterile container formation and filling under stringent EU GMP Annex 1 conditions, as well as Insertion Technology that facilitates cost-effective production of prefilled syringes, multidose droppers, and other delivery devices. The DUO platform supports PE, HDPE, and PP materials with rapid mould changeovers, reduces plastic scrap to below 6%, and enables cold-temperature production of vaccines and biologics below 25°C, capabilities unprecedented in a closed-parison BFS machine.
Blow-Fill-Seal Technology Market Key Players Shaping Industry Direction
Major companies operating in the blow-fill-seal technology market are Amanta Healthcare Ltd.; Unither Pharmaceuticals SAS; Weiler Engineering Inc.; GlaxoSmithKline PLC; Nephron Pharmaceuticals Corporation; Brevetti Angela SRL; Recipharm AB; Rommelag Kunststoff-Maschinen Vertriebsgesellschaft mbH; Unicep Packaging LLC; Catalent Inc.; The Ritedose Corporation; Birgi Mefar Group; Takeda Pharmaceutical Company Limited; Pfizer Inc.; Sanofi SA; Novartis International AG; Merck & Co. Inc.; Johnson & Johnson Private Limited; Teva Pharmaceutical Industries Ltd.; AstraZeneca PLC; F Hoffmann-La Roche Ltd.; Fresenius Kabi AG; B. Braun Melsungen AG; Sandoz International GmbH; Baxter International Inc.; West Pharmaceutical Services Inc.; Gerresheimer AG
View The Full Blow-Fill-Seal Technology Market Report:
Blow-Fill-Seal Technology Market Regional Analysis: Which Geography Leads On Revenue?
North America was the largest region in the blow-fill-seal technology market in 2025. The regions covered in the blow-fill-seal technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
